drugset / Trial / NCT00742443

Juvista in Scar Revision Surgery of Disfiguring Scars

NCT00742443

Phase 3 Completed 350 enrolled Renovo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

This trial is to determine whether Juvista can prevent scar formation or improve the appearance of scars following scar revision surgery. The trial will involve comparing Juvista to placebo.

Timeline

Start
2008-12
Primary completion
2011-01
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Avotermin Protein / enzyme biologic 100 ng Other
Subject Avotermin Protein / enzyme biologic 250 ng Other

Indications

No indication recorded.